TODD E. SIMPSON - 11 May 2021 Form 4 Insider Report for Neoleukin Therapeutics, Inc. (NGNE)

Role
Director
Signature
/s/ Kris McGrew, Attorney-in-Fact for Todd E. Simpson
Issuer symbol
NGNE
Transactions as of
11 May 2021
Net transactions value
$0
Form type
4
Filing time
13 May 2021, 17:38:43 UTC
Next filing
18 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NLTX Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 11 May 2021 Common Stock 25,000 $11.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/12 of the total shares monthly beginning June 11, 2021 until the option is fully vested on May 11, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date.